Mutations in about 400 different genes have been associated with Cognitive Disorders (CD), such as autism, neurodegenerative disorders, and psychiatric disorders. Whereas CD collectively impose a major medical and socio‐economical problem, there are no systematic studies that aim to provide insight into common pathogenic mechanisms in CD. The GENCODYS consortium proposes a systems biology approach, with a focus on mental retardation and autism, to reveal the common molecular and cellular mechanisms leading to cognitive impairment.
As a partner in this consortium, EGAN will stimulate, facilitate and organise the interaction between the scientific partners in GENCODYS and patient organisations. The GENCODYS consortium is funded by the European Union under the 7th framework program.